Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis

被引：0
|
作者：
Zhong, Xinxin [1 ]
Lin, Ao [2 ]
Luo, Jian [1 ]
Li, Yeqin [1 ]
Chen, Jinlan [1 ]
Ning, Chao [1 ]
Cao, Fu [1 ,3 ]
机构：
[1] Red Cross Hosp Yulin City, Dept Pulm & Crit Care Med, Yulin 537000, Guangxi, Peoples R China
[2] Red Cross Hosp Yulin City, Dept Cardiothorac Surg, Yulin 537000, Guangxi, Peoples R China
[3] Red Cross Hosp Yulin City, Dept Pulm & Crit Care Med, 1 Jinwang Rd, Yulin 537000, Guangxi, Peoples R China
来源：
POSTGRADUATE MEDICAL JOURNAL | 2024年 / 100卷 / 1184期
关键词：
antituberculosis drugs; multidrug-resistance; mycobacterium; chemotherapy; MYCOBACTERIUM-TUBERCULOSIS; BACTERICIDAL ACTIVITY; IN-VITRO; MDR-TB; BEDAQUILINE; REGIMENS; PRETOMANID; DISCOVERY; DELAMANID; EFFICACY;
D O I：
10.1093/postmj/qgad140
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Multidrug-resistant tuberculosis (MDR-TB) has become a critical challenge to public health, and the prevention and treatment of MDR-TB are of great significance in reducing the global burden of tuberculosis. How to improve the effectiveness and safety of chemotherapy for MDR-TB is a pressing issue that needs to be addressed in tuberculosis control efforts. This article provides a comprehensive review of the clinical application of new antituberculosis drugs in MDR-TB, aiming to provide a scientific basis for the prevention and treatment strategy of MDR-TB.
引用
收藏
页码：366 / 372
页数：7
相关论文
共 50 条
  • [21] Bedaquiline: A novel antitubercular drug for multidrug-resistant tuberculosis
    Nagabushan, H.
    Roopadevi, H. S.
    JOURNAL OF POSTGRADUATE MEDICINE, 2014, 60 (03) : 300 - 302
  • [22] Bedaquiline: An Insight Into its Clinical Use in Multidrug-Resistant Pulmonary Tuberculosis
    Ahmad, Asad
    Akhtar, Juber
    Ahmad, Mohammad
    Badruddeen
    Khan, Mohammad Irfan
    Wasim, Rufaida
    Islam, Anas
    Singh, Aditya
    DRUG RESEARCH, 2024, 74 (06) : 269 - 279
  • [23] An update on multidrug-resistant tuberculosis
    Park, Mirae
    Satta, Giovanni
    Kon, Onn Min
    CLINICAL MEDICINE, 2019, 19 (02) : 135 - 139
  • [24] Linezolid for multidrug-resistant tuberculosis
    Chang, Kwok-Chiu
    Leung, Chi-Chiu
    Daley, Charles L.
    LANCET INFECTIOUS DISEASES, 2012, 12 (07) : 502 - 503
  • [25] Current therapies for the treatment of multidrug-resistant tuberculosis in children in India
    Mukherjee, Aparna
    Lodha, Rakesh
    Kabra, Sushil Kumar
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1595 - 1606
  • [26] Profile of delamanid for the treatment of multidrug-resistant tuberculosis
    Szumowski, John D.
    Lynch, John B.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 677 - 682
  • [27] Multidrug-resistant tuberculosis
    Moreira Lemos, Antonio Carlos
    Matos, Eliana Dias
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (02) : 239 - 246
  • [28] Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives
    Rendon, Adrian
    Tiberi, Simon
    Scardigli, Anna
    D'Ambrosio, Lia
    Centis, Rosella
    Caminero, Jose A.
    Migliori, Giovanni Battista
    JOURNAL OF THORACIC DISEASE, 2016, 8 (10) : 2666 - 2671
  • [29] New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis Practice-based Recommendations
    Harausz, Elizabeth P.
    Garcia-Prats, Anthony J.
    Seddon, James A.
    Schaaf, H. Simon
    Hesseling, Anneke C.
    Achar, Jay
    Bernheimer, Jonathan
    Cruz, Andrea T.
    D'Ambrosio, Lia
    Detjen, Anne
    Graham, Stephen M.
    Hughes, Jennifer
    Jonckheere, Sylvie
    Marais, Ben J.
    Migliori, Giovanni Battista
    McKenna, Lindsay
    Skrahina, Alena
    Tadolini, Marina
    Wilson, Peyton
    Furin, Jennifer
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (10) : 1300 - 1310
  • [30] DELAWANID FOR THE TREATMENT OF PULMONARY MULTIDRUG-RESISTANT TUBERCULOSIS
    Thakare, R.
    Soni, I.
    Dasgupta, A.
    Chopra, S.
    DRUGS OF TODAY, 2015, 51 (02) : 117 - 123
12345